share_log

Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Remi Barbier(5.7%)

Cassava Sciences | SC 13G/A:超過5%持股股東披露文件(修正)-Remi Barbier(5.7%)

SEC announcement ·  02/02 05:03
牛牛AI助理已提取核心訊息
Cassava Sciences, Inc., a biotechnology company, has filed an amended Schedule 13G/A with the U.S. Securities and Exchange Commission (SEC) on February 1, 2024. The filing indicates that Remi Barbier, President, CEO, and Chairman of Cassava Sciences, beneficially owns 2,488,531 shares of the company's common stock, representing 5.7% of the class. The document details that Barbier has sole voting and dispositive power over 1,778,465 shares and shared voting and dispositive power over 710,066 shares. The filing, dated December 31, 2023, is a routine disclosure that specifies the ownership percentage and voting rights of significant shareholders. It also includes a certification by Barbier, stating that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Cassava Sciences, Inc., a biotechnology company, has filed an amended Schedule 13G/A with the U.S. Securities and Exchange Commission (SEC) on February 1, 2024. The filing indicates that Remi Barbier, President, CEO, and Chairman of Cassava Sciences, beneficially owns 2,488,531 shares of the company's common stock, representing 5.7% of the class. The document details that Barbier has sole voting and dispositive power over 1,778,465 shares and shared voting and dispositive power over 710,066 shares. The filing, dated December 31, 2023, is a routine disclosure that specifies the ownership percentage and voting rights of significant shareholders. It also includes a certification by Barbier, stating that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
生物技術公司木薯科學公司已於2024年2月1日向美國證券交易委員會(SEC)提交了經修訂的附表13G/A。該文件顯示,木薯科學總裁、首席執行官兼董事長雷米·巴比爾實益擁有該公司普通股的2,488,531股,佔該類別的5.7%。該文件詳細說明,巴比爾對1,778,465股股票擁有唯一的投票權和處置權,對710,066股股票擁有共同的投票權和處置權。該文件日期爲2023年12月31日,是一份例行披露,具體說明了大股東的所有權百分比和投票權。它還包括Barbier的認證,該證明表明這些股票是在正常業務過程中收購的,不是爲了改變或影響發行人的控制權。
生物技術公司木薯科學公司已於2024年2月1日向美國證券交易委員會(SEC)提交了經修訂的附表13G/A。該文件顯示,木薯科學總裁、首席執行官兼董事長雷米·巴比爾實益擁有該公司普通股的2,488,531股,佔該類別的5.7%。該文件詳細說明,巴比爾對1,778,465股股票擁有唯一的投票權和處置權,對710,066股股票擁有共同的投票權和處置權。該文件日期爲2023年12月31日,是一份例行披露,具體說明了大股東的所有權百分比和投票權。它還包括Barbier的認證,該證明表明這些股票是在正常業務過程中收購的,不是爲了改變或影響發行人的控制權。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。